Literature DB >> 3560382

National adverse drug reaction surveillance: 1985.

G A Faich, D Knapp, M Dreis, W Turner.   

Abstract

The Food and Drug Administration received about 37,000 adverse drug reaction reports in 1985. Seventy-one percent of the reports involved toxic reactions to usual doses of drugs and were sent by medical care professionals directly to the Food and Drug Administration or to pharmaceutical manufacturers. In terms of severity, 2% of reports involved death while 21% involved hospitalization. The highest proportions of hospitalization or death were found for reports describing cardiovascular, hematologic, or respiratory effects. Nearly half of the reported deaths were in patients more than 59 years of age. The majority of reports described an adverse drug reaction occurring within two weeks of initial exposure to the suspected drug. Adverse drug reaction reporting by physicians is crucial to ensuring that pharmaceutical products are used appropriately.

Entities:  

Mesh:

Year:  1987        PMID: 3560382

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

1.  Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions.

Authors:  L Naldi; A Conforti; M Venegoni; M G Troncon; A Caputi; E Ghiotto; A Cocci; U Moretti; G Velo; R Leone
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

2.  Using computerized data to identify adverse drug events in outpatients.

Authors:  B Honigman; J Lee; J Rothschild; P Light; R M Pulling; T Yu; D W Bates
Journal:  J Am Med Inform Assoc       Date:  2001 May-Jun       Impact factor: 4.497

3.  Development of a computerized adverse drug event monitor.

Authors:  R S Evans; S L Pestotnik; D C Classen; S B Bass; R L Menlove; R M Gardner; J P Burke
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1991

4.  Emergency department visits caused by adverse drug events: results of a French survey.

Authors:  Patrice Queneau; Bernard Bannwarth; Françoise Carpentier; Jean-Michel Guliana; Jacques Bouget; Béatrice Trombert; Xavier Leverve; Frédéric Lapostolle; Stephen W Borron; Frédéric Adnet
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area.

Authors:  A Conforti; R Leone; U Moretti; F Mozzo; G Velo
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

Authors:  Roberto Leone; Mauro Venegoni; Domenico Motola; Ugo Moretti; Valentina Piazzetta; Alfredo Cocci; Domenico Resi; Federico Mozzo; Giampaolo Velo; Liliana Burzilleri; Nicola Montanaro; Anita Conforti
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

7.  Prevention of adverse drug events through computerized surveillance.

Authors:  R S Evans; S L Pestotnik; D C Classen; S B Bass; J P Burke
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1992

8.  Using a hospital information system to assess the effects of adverse drug events.

Authors:  R S Evans; D C Classen; L E Stevens; S L Pestotnik; R M Gardner; J F Lloyd; J P Burke
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1993

Review 9.  The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity.

Authors:  Volker M Lauschke; Magnus Ingelman-Sundberg
Journal:  Int J Mol Sci       Date:  2016-10-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.